Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Uterine Cervical Neoplasms 13Prostatic Neoplasms 6Sarcoma 4Breast Neoplasms 4Radiation Injuries 2Carcinoma, Ductal, Breast 2Obesity 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Fatigue 1Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1Endometrial Clear Cell Adenocarcinoma 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Anemia 1

Interventions

Tamoxifen 3Radiotherapy 3Magnetic Resonance Spectroscopy 2Chemotherapy, Adjuvant 2Steroids 1Risedronic Acid 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Pharmacogenomic Testing 1Medroxyprogesterone 1Gene Expression Profiling 1Cholecalciferol 1Brachytherapy 1Anastrozole 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Intraductal, Noninfiltrating × Brachytherapy × Clear all
NCT00103181 2022-04-14

Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer

NSABP Foundation Inc

Phase NA Completed
4,216 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡